<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="8303">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01998204</url>
  </required_header>
  <id_info>
    <org_study_id>Parkinson-propofol</org_study_id>
    <nct_id>NCT01998204</nct_id>
  </id_info>
  <brief_title>Requirement of Propofol for Induction of Unconsciousness in Patients With Parkinson's Disease</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Changhai Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Changhai Hospital</source>
  <oversight_info>
    <authority>China: National Natural Science Foundation</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Parkinson's disease (PD) is the second most prevalent neurodegenerative disease. The
      investigators clinical experience showed a trend of delayed emergence among patients
      undergoing deep brain stimulator (DBS) implantation and pulse generator placement under
      general anesthesia. Abnormal pharmacodynamics might be present among these patients, which
      had never been investigated.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2012</start_date>
  <completion_date type="Actual">June 2013</completion_date>
  <primary_completion_date type="Actual">June 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case Control, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Consciousness status</measure>
    <time_frame>Participants will be monitored during the period of propofol infusion, an expected average of less than 10 min</time_frame>
    <safety_issue>No</safety_issue>
    <description>Consciousness status is evaluated by the observer's assessment of alertness and sedation score (OAA/S).</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">62</enrollment>
  <condition>Parkinson's Disease</condition>
  <arm_group>
    <arm_group_label>PD group</arm_group_label>
    <description>Patients with Parkinson's disease undergoing deep brain stimulator implantation and pulse generator placement</description>
  </arm_group>
  <arm_group>
    <arm_group_label>non-PD group</arm_group_label>
    <description>Patients without Parkinson's disease undergoing intracranial surgery</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Our study recruits patients with Parkinson's disease undergoing deep brain stimulator
        implantation and pulse generator placement under general anesthesia and non-Parkinsonian
        patients without Parkinson's disease undergoing intracranial surgery under general
        anesthesia
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with Parkinson's disease undergoing deep brain stimulator implantation and
             pulse generator placement under general anesthesia

          -  non-Parkinsonian patients without Parkinson's disease undergoing intracranial surgery
             under general anesthesia

        Exclusion Criteria:

          -  ASA score higher than Class III

          -  predicted difficult airway

          -  hearing impairment

          -  inability to corporate with instruction

          -  alcohol or drug abuser

          -  patients refusing to provide informed consent
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jia-feng Wang, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Anesthesiology, Changhai Hospital, Second Military Medical University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Anesthesiology, Changhai Hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200433</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <lastchanged_date>November 23, 2013</lastchanged_date>
  <firstreceived_date>November 19, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Changhai Hospital</investigator_affiliation>
    <investigator_full_name>Jia-feng Wang</investigator_full_name>
    <investigator_title>Dr.</investigator_title>
  </responsible_party>
  <keyword>Parkinson's disease</keyword>
  <keyword>propofol</keyword>
  <keyword>deep brain stimulator</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Parkinson Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
